HHS will permit compounding of six peptides ahead of formal rulemaking
The US Food and Drug Administration (FDA) issued revised draft guidance on Thursday aimed at assisting sponsors of drug-device combination products in designing and developing…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 16:51 ETSource: RAPS
From the source
Read at raps.orgHHS will permit compounding of six peptides ahead of formal rulemaking
The US Food and Drug Administration (FDA) issued revised draft guidance on Thursday aimed at assisting sponsors of drug-device combination products in designing and developing essential drug delivery device performance characteristics (EDDCs) for their products.
